Suppliers / Baxter Hospitalar Ltda

Baxter Hospitalar Ltda

Brazil Updated 9 July 2026

Baxter Hospitalar Ltda is a finished-dose manufacturer based in Brazil. It appears in 1,521 regulatory filings across 31 regulators, without an active US DMF or CEP on file. Its filings concentrate with Health Canada, ANVISA (Brazil) and FAMHP (BE). Its GMP standing is certified by ANSM (FR), MFDS (Korea) and EMA, among 9 authorities.

0
active US DMFs
0
valid CEPs
12
registered plants
1,521
filings across 31 regulators
These figures were checked against the regulators' own files on 25 July 2026
EU GMP
1 of 1 confirmed
Sources: EudraGMDP (MIA + third-country GMP certs), read 4 May 2026.

Registered plants

Site FDA FEI
Dammam, United Arab Emirates Not on file
Bloomington, United Arab Emirates Not on file
Lessines, United Arab Emirates Not on file
Lessines, United Arab Emirates Not on file
Braine-l'Alleud, Belgium Not on file
São Paulo, Brazil Not on file

6 further sites are on record.

Filings and GMP by regulator

Regulator Filings GMP certificates
Health Canada 348 None
ANVISA (Brazil) 167 1
FAMHP (BE) 151 None
EMA 151 4
INHRR (VE) 97 None
DIGEMAPS (DO) 90 None
ANSM (FR) None 9
MFDS (Korea) None 4
COFEPRIS (MX) None 2
INVIMA (CO) None 2
SFDA (Saudi Arabia) None 1
NAFDAC (NG) None 1
MHRA (UK) None 1

Scale

Year Revenue Exports Destinations
2024 $44.9M Not reported Not reported

Export figures are customs aggregates. We do not publish the identity of any buyer. Revenue shown in US dollars, converted from the reported currency.

Comparing suppliers?

Choose your molecules and target markets. Baxter Hospitalar Ltda comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability
EudraGMDP and national regulators
GMP certificates
Company filings
Revenue as reported